A blockchain-based company MediConnect proudly announces the successful completion of the Proof-of-Concept workflow (PoC) and is all set to integrate the online pharmacy retailer and partner company UK Meds, to its MediConnect PoC platform.
MediConnect is the only company that offers blockchain solutions to tackle real-time challenges concerning the pharmaceutical industry. The completed workflow marks as a milestone for the blockchain startup that aims to streamline the supply chain by efficiently tracking the circulation of medications, right from its manufacturer to the user. The parameters established for the workflow have been carefully curated after consulting with several medical professionals and pharmaceutical experts.
By next year, it hopes to complete pilot testing that would include up to ten participants from the industry. With UK Meds’ integration, it will verify the products entering the supply chain, thus preventing counterfeit drugs from entering the markets.
UK Meds is the country’s fastest-growing online pharmacy retailer with a consumer base of forty thousand, uploading thousands of prescriptions on its website every day. Thus, the initiative is expected to make a significant impact on the supply and distribution of genuine medication.
Early applications of Proof-of-Concept workflow
Earlier this year, it joined hands with the Ugandan government for addressing similar issues that grapple the country’s pharmaceuticals. Similar to its current application in UK Meds, the blockchain-based solutions accurately register the medicines entering the supply chain and track their activities from manufacturing, prescription to purchase.
Blockchain has been successfully integrated into healthcare and supply chain as major pharmaceutical organizations have started paying heed to its capabilities. Recently, the Ministry of Health and Prevention in UAE enabled precise recording, storing and sharing of healthcare records of patients.
